Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
European Journal of Haematology|November 29, 2016
Sorafenib and azacitidine as salvage therapy for relapse of FLT3-ITD mutated AML after allo-SCTChristina Rautenberg, Kathrin Nachtkamp, Ariane Dienst, et al.
Scientific Reports|July 4, 2023
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experiencePaul Jäger, Christina Rautenberg, Jennifer Kaivers, et al.
Cancers|December 23, 2022
Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic ComponentVictoria Platte, Anika Bergmann, Barbara Hildebrandt, et al.
Annals of Hematology|March 30, 2019
Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignanciesEsther Schuler, Sarah Boughoufala, Christina Rautenberg, et al.
Cancers|August 19, 2020
Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell TransplantationChristina Rautenberg, Anika Bergmann, Ulrich Germing, et al.
Transplantation and Cellular Therapy|June 4, 2025
Pilot Study of Low-Dose Splenic Irradiation and Transplantation in JAK Inhibitor-Refractory Myelofibrosis With SplenomegalyKristin Rathje, Nico Gagelmann, Artur Schneider, et al.
Transplantation and Cellular Therapy|October 13, 2025
Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in RemissionJacob Pyka, Judith Metzdorf, Christian Reicherts, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2018
Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell TransplantationChristina Rautenberg, Sabrina Pechtel, Barbara Hildebrandt, et al.
Annals of Hematology|November 20, 2017
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupThomas Schroeder, Christina Rautenberg, William Krüger, et al.
Transplantation and Cellular Therapy|March 9, 2025
Outcome of Patients With IDH-Mutated AML Following Allogeneic Stem Cell Transplantation-A Retrospective Analysis on Behalf of the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy, DRSTThomas Schroeder, Sarah Flossdorf, Claudia Schuh, et al.
Pageof 4